Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2026-04-26 @ 12:19 PM
Study NCT ID:
NCT01810718
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2013-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD
Sponsor:
Gruppo Italiano Trapianto di Midollo Osseo
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GITMO Protocol Nilotinib-cGVHD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None